Trial intelligence / Profile preview

Phase I/II study of HEC169096 in advanced RET-altered solid tumors

CTR20221281Phase 2Terminated

Sponsor

HEC Pharm

Start

Oct 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1